Improving cancer risk assessment for diverse and underserved populations using a patient app
Inclusion of Diverse and Medically Underserved Populations in the Design and Implementation of the PREMMplus Patient-Facing App
This study is working on improving a helpful app that looks at family history and genetic information to find out who might be at risk for hereditary cancers, especially focusing on making sure that everyone, including those from diverse and underserved communities, can easily access this important information and support.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10942996 on NIH RePORTER |
What this research studies
This research focuses on enhancing the PREMMplus patient-facing app to ensure that diverse and medically underserved populations are included in hereditary cancer risk assessments. By utilizing family history and genetic testing data, the app aims to identify individuals at significant risk for carrying genetic variants associated with various hereditary cancers. The project will involve community engagement to address barriers and improve access to genetic testing and risk assessment services. The goal is to implement a more equitable approach to cancer risk evaluation, ensuring that all patients, regardless of background, can benefit from these advancements.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals from diverse and medically underserved backgrounds who may be at risk for hereditary cancers.
Not a fit: Patients who do not have a family history of hereditary cancers or those who are not interested in genetic testing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier identification and better management of hereditary cancer risks for underserved populations.
How similar studies have performed: Previous research has shown success in using technology to improve access to genetic testing and risk assessment, indicating that this approach has potential for positive outcomes.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Syngal, Sapna — Dana-Farber Cancer Inst
- Study coordinator: Syngal, Sapna
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.